NewEdge Wealth LLC Takes Position in Align Technology, Inc. $ALGN

Posted by on Jul 26th, 2026

NewEdge Wealth LLC bought a new position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) in the first quarter, HoldingsChannel.com reports. The fund bought 11,959 shares of the medical equipment provider’s stock, valued at approximately $2,050,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Capital International Investors boosted its stake in Align Technology by 52.2% in the 4th quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider’s stock valued at $725,039,000 after buying an additional 1,592,848 shares in the last quarter. Invesco Ltd. raised its stake in Align Technology by 37.4% during the third quarter. Invesco Ltd. now owns 1,497,535 shares of the medical equipment provider’s stock worth $187,521,000 after acquiring an additional 407,559 shares in the last quarter. Capital World Investors raised its stake in Align Technology by 13.2% during the fourth quarter. Capital World Investors now owns 1,490,503 shares of the medical equipment provider’s stock worth $232,742,000 after acquiring an additional 173,641 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of Align Technology by 72.0% during the third quarter. Bank of America Corp DE now owns 1,353,125 shares of the medical equipment provider’s stock valued at $169,438,000 after acquiring an additional 566,488 shares during the period. Finally, Ruane Cunniff & Goldfarb L.P. bought a new position in shares of Align Technology during the fourth quarter valued at $190,899,000. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

Shares of NASDAQ:ALGN opened at $167.01 on Friday. The business has a fifty day moving average of $173.31 and a 200-day moving average of $175.01. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $208.30. The firm has a market cap of $11.96 billion, a PE ratio of 28.02, a price-to-earnings-growth ratio of 1.71 and a beta of 1.67.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.26 by $0.32. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the company earned $2.13 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. On average, analysts anticipate that Align Technology, Inc. will post 9.48 EPS for the current fiscal year.

Align Technology announced that its board has approved a stock buyback plan on Wednesday, April 29th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 1.6% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on ALGN shares. Citigroup started coverage on shares of Align Technology in a report on Wednesday, April 15th. They issued a “buy” rating and a $240.00 target price on the stock. BMO Capital Markets began coverage on shares of Align Technology in a report on Wednesday, July 8th. They set an “outperform” rating and a $209.00 price target for the company. UBS Group restated a “neutral” rating and issued a $189.00 price target on shares of Align Technology in a research report on Thursday. Zacks Research cut shares of Align Technology from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 16th. Finally, Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $206.36.

Read Our Latest Research Report on ALGN

Align Technology Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Featured Articles

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.